State Street’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.4M | Buy |
1,776,401
+5,713
| +0.3% | +$20.6K | ﹤0.01% | 2829 |
|
|
2025
Q1 | $5.29M | Sell |
1,770,688
-15,390
| -0.9% | -$46K | ﹤0.01% | 2856 |
|
|
2024
Q4 | $5.98M | Buy |
1,786,078
+52,592
| +3% | +$176K | ﹤0.01% | 2883 |
|
|
2024
Q3 | $5.81M | Buy |
1,733,486
+11,566
| +0.7% | +$38.7K | ﹤0.01% | 2896 |
|
|
2024
Q2 | $5.7M | Buy |
1,721,920
+43,537
| +3% | +$144K | ﹤0.01% | 2861 |
|
|
2024
Q1 | $6.78M | Buy |
1,678,383
+48,346
| +3% | +$195K | ﹤0.01% | 2793 |
|
|
2023
Q4 | $4.97M | Buy |
1,630,037
+123,800
| +8% | +$378K | ﹤0.01% | 2947 |
|
|
2023
Q3 | $4.52M | Sell |
1,506,237
-27,051
| -2% | -$81.2K | ﹤0.01% | 2967 |
|
|
2023
Q2 | $5.73M | Sell |
1,533,288
-330,049
| -18% | -$1.23M | ﹤0.01% | 2931 |
|
|
2023
Q1 | $6.24M | Sell |
1,863,337
-74,393
| -4% | -$249K | ﹤0.01% | 2906 |
|
|
2022
Q4 | $9.32M | Buy |
1,937,730
+42,994
| +2% | +$207K | ﹤0.01% | 2738 |
|
|
2022
Q3 | $10.8M | Buy |
1,894,736
+91,368
| +5% | +$520K | ﹤0.01% | 2663 |
|
|
2022
Q2 | $12.8M | Sell |
1,803,368
-68,706
| -4% | -$488K | ﹤0.01% | 2550 |
|
|
2022
Q1 | $13.5M | Sell |
1,872,074
-453,379
| -19% | -$3.27M | ﹤0.01% | 2654 |
|
|
2021
Q4 | $20.8M | Buy |
2,325,453
+1,222,601
| +111% | +$10.9M | ﹤0.01% | 2454 |
|
|
2021
Q3 | $38.7M | Buy |
1,102,852
+141,085
| +15% | +$4.95M | ﹤0.01% | 1992 |
|
|
2021
Q2 | $20.7M | Buy |
961,767
+677,244
| +238% | +$14.5M | ﹤0.01% | 2487 |
|
|
2021
Q1 | $17.6M | Buy |
284,523
+61,849
| +28% | +$3.82M | ﹤0.01% | 2444 |
|
|
2020
Q4 | $9.3M | Buy |
+222,674
| New | +$9.3M | ﹤0.01% | 2671 |
|